Skip to main content
OpenTrials

Clinical trial condition

Malaria

Explore clinical trials studying Malaria. Study availability and eligibility vary by location and protocol.

937 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

Malaria trial results

Completed

A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria

NCT06069544

Conditions
Infections, Malaria, Malaria, Falciparum, +4 more
Locations
  • AMR Tempe Tempe, Arizona, United States
  • University of Maryland, Center for Vaccine Development Baltimore, Maryland, United States
  • AMR Las Vegas Las Vegas, Nevada, United States
  • AMR Knoxville Knoxville, Tennessee, United States
View Trial Details
Completed

To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria

NCT04675931

Conditions
Infections, Malaria, Mosquito-Borne Diseases, +4 more
Locations
  • Novartis Investigative Site Burkina Faso
  • Novartis Investigative Site Ouagadougou, Burkina Faso
  • Novartis Investigative Site Abidjan, Côte d’Ivoire
  • Novartis Investigative Site Agboville, Côte d’Ivoire
View Trial Details
Completed

Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines

NCT05155579

Conditions
Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations
  • Malaria Research & Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Medicine, Pharmacy and Dentistry, University of Sciences Techniques and Technologies of Bamako Bamako, Mali
  • CCVTM, University of Oxford Oxford, United Kingdom
View Trial Details
Completed

A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa

NCT03855995

Conditions
Infections, Malaria, Malaria Vaccines, +5 more
Locations
  • GSK Investigational Site Kintampo, Ghana
  • GSK Investigational Site Navrongo, Ghana
  • GSK Investigational Site Kisumu, Kenya
  • GSK Investigational Site Kisumu, Kenya
View Trial Details
Completed

Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)

NCT05974267

Conditions
Asymptomatic Diseases, Asymptomatic Infections, Disease Attributes, +10 more
Locations
  • Groupe de Recherche Action en Sante (GRAS) Ouagadougou, Burkina Faso
  • Kisumu County Referral Hospital Kisumu, Kenya
  • MRC Unit The Gambia at LSHTM Banjul, The Gambia
  • Ndola Teaching Hospital Ndola, Zambia
View Trial Details

Related conditions